Paul Laikind

Dr. Laikind earned a PhD in Chemistry from UC, San Diego and has served as a research faculty member at the UC, San Diego School of Medicine. Dr. Laikind founded Gensia Inc. in 1986 and was Vice President of Business Development and a Director at Gensia where he was responsible for establishing major research and development corporate partnerships with leading U.S. and European companies. While at Gensia, Dr. Laikind also founded Viagene Inc. a biotechnology company acquired by Chiron Inc. in 1995. He went on to be a co-founder, Chairman of the Board, President and Chief Executive Officer for Metabasis. Dr. Laikind has served as Chairman of BIOCOM, served on the Board of the San Diego Chapter of the American Liver Foundation, and been a member of BIO Emerging Companies Section Governing Body.

Interview – May 14, 1997

Interviewed by Mark Jones, PhD

At the time of this interview, Dr. Laikind was co-founder, Chief Executive Officer and President of Metabasis Therapeutics.